Farallon Capital Partners, L.P. 13D and 13G filings for Tyra Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-12 08:54 am Purchase | 2026-03-31 | 13G | TYRA BIOSCIENCES INC TYRA | Farallon Capital Partners, L.P. | 3,580,818 6.600% | 596,000 (+19.97%) | Filing |
| 2026-02-20 08:14 am Purchase | 2026-02-12 | 13G | TYRA BIOSCIENCES INC TYRA | Farallon Capital Partners, L.P. | 2,984,818 5.600% | 2,984,818 (New Position) | Filing |